Evaluation of an omega-3 fatty acid supplement in diabetics with microalbuminuria.
Lungershausen
Y K
YK
CSIRO Division of Human Nutrition, Adelaide, Australia.
Howe
P R
PR
Clifton
P M
PM
Hughes
C R
CR
Phillips
P
P
Graham
J J
JJ
Thomas
D W
DW
D000419:Albuminuria / Q000178:diet therapy* / Q000209:etiology / Q000503:physiopathology; D001794:Blood Pressure / Q000187:drug effects; D003404:Creatinine / Q000652:urine; D003924:Diabetes Mellitus, Type 2 / Q000150:complications* / Q000503:physiopathology / Q000652:urine; D004311:Double-Blind Method; D015525:Fatty Acids, Omega-3 / Q000008:administration & dosage*; D006801:Humans
D015525:Fatty Acids, Omega-3; D003404:Creatinine